Accéder au contenu
Merck

Failure of the biguanide moroxydine chloride to stimulate plasma fibrinolytic activity.

Acta medica Scandinavica (1984-01-01)
M Boberg, A Killander
RÉSUMÉ

Eleven patients with recurrent venous thrombosis or thrombophlebitis and a decreased fibrinolytic activity after venous occlusion were given a phenformin-like substance, moroxydine chloride, for 6 months. No sustained increase in the fibrinolytic activity was observed after moroxydine treatment.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Moroxydine hydrochloride, 99%